(Total Views: 152)
Posted On: 07/25/2019 8:00:43 AM
Post# of 103695
$MTNB News Article - Matinas BioPharma Receives Qualified Infectious Disease Product (QIDP) and Fast Track Designations From U.S. FDA for MAT2203 for the Treatment of Cryptococcal Meningitis https://marketwirenews.com/news-releases/mati...17258.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼